- Phivida
has been awarded DTC and CNS eligibility for its common shares
- Company
is a premium food and beverage leader in the use of infused cannabinoids
- Phivida’s
mission is to help lessen the world’s dependence on pharmaceuticals
Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is a
premium functional food and beverage business based in Vancouver, British
Columbia. The company infuses all of its products with organic cannabinoids
from hemp, and it offers premium beverages and clinical products for everyday
health.
Phivida recently announced that it has been awarded full DTC
(Depository Trust Company) and CNS (Continuous-Net-Settlement) eligibility for
its common shares listed for trading on the OTCQX® Best Market under the symbol
“PHVAF” in the U.S. (http://ibn.fm/m8WdI).
DTC’s emphasis is worldwide trading activity. It processes
trillions of dollars of securities transactions daily. DTC provides an
electronic process of clearing securities that expedites the receipt of stock
and cash while speeding up the settlement process. CNS is an automated
book-entry accounting system. Its focus is on centralizing the settlement of
security transactions. It does so while maintaining an organized flow of
security and money balances between those participating in the market.
Phivida’s expectation is that achieving DTC and CNS
eligibility will simplify and fast-track settlement for investors while
boosting the liquidity of its common shares on the OTC Market. CNS eligibility
ensures that all DTC eligible trades and cash balances are centralized, cleared
and settled in an efficient and systematic way.
Regarding its business, Phivida’s belief is that overall
body health and balance are best maintained through whole plant nutrition and
natural ingredients. Phivida sources its products from premier organic hemp and
natural ingredients. These products are third-party lab tested for quality,
purity and potency at world-class facilities. Hemp is a source of full-spectrum
cannabinoids and is high CBD/low THC.
Phivida’s product line-up includes beverages, capsules and
tinctures. Oki is its newest brand of hemp extract-infused flavored iced teas,
flavor-infused waters and tinctures and capsules. In addition, the company
offers the Vida+ line of premium hemp-infused products, including hemp oil
extract and hemp oil capsules.
Phivida is cGMP-compliant (Current Good Manufacturing
Practice) to ensure pharmaceutical quality. The company fuses ancient eastern
traditions of whole plant medicine with contemporary western principles of
naturopathic science. Phivida employs encapsulation technology. It converts
phytocannabinoids into a water-soluble delivery format. This format improves
bioavailability and timed released within the body.
Recently, Phivida signed an agreement with Acosta’s National
Specialty Sales division, which gives the company access to 2,400 national
specialty retailers throughout the United States.
Moreover, Phivida and WeedMD (OTC: WDDMF) have signed a final
definitive Joint Venture (JV) agreement. This agreement is to develop and
operate Cannabis Beverages, Inc. (CanBev), with each company retaining 50
percent of the Class A shares in CanBev.
For more information, visit the company’s website at www.Phivida.com
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment